Navigation Links
Device That Targets Brain Cancer Shows Promising Results

Early data for an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields , called Tumor-Treating Fields (TTFields), has found that it more than doubled the median overall survival rates in patients with the most common and aggressive type of malignant brain tumor.

The device, called the Novo-TTF, uses electrical fields to disrupt tumor growth by interfering with cell division of cancerous cells, causing them to stop proliferating and die off instead of dividing and growing.

Healthy brain cells rarely divide and have different electrical properties than cancerous brain cells. This allows the device to target cancer cells without affecting the healthy cells.

The 10 patients who were being treated with the device were suffering from recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.

Researchers found that among the patients treated with the Novo-TTF, the median length of time to disease progression was 26.1 weeks; progression free survival at six months was 50 percent; and median overall survival was 62.2 weeks.

This is more than double the rates reported in historical data approximately 9.5 weeks, 15.3 percent, and 29.3 weeks, respectively.

"The novel mechanism of action of the Novo-TTF relies on the physical properties of the cancer cells, their shape and size, rather than the chemical make-up. We believe that this distinction enables the device to stop local proliferation and metastasis of cancer, which would explain the efficacy observed in these early findings," said Dr. Elion Kirson lead author and Vice President of Research and Development, NovoCure.

"Based on our preliminary research, we believe that there is a high probability that TTFields may prove to be an effective and safe approach to treating a large number of human cancers," Dr Kirson a
'"/>




Page: 1 2

Related medicine news :

1. Injection supports Heart Devices
2. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
3. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. New Implantable Device That Can Keep The Heart Ticking
6. Making MRIs Safe for Patients With Implantable Heart Devices
7. Researchers Develop Device For Detecting Atherosclerotic Plaques
8. A Cheap Device to Stop Snoring from New Zealand
9. Scientists Concerned Over Increasing Malfunction Of Heart Devices
10. Device For Improving Bone Mass In Osteoporosis
11. Anti-Microbial Coating For Use Over Biomedical Devices Developed
Post Your Comments:
(Date:10/7/2008)...oduces Color Me Healthy(TM)/Salud Primero to teach...ulum, BENSENVILLE, Ill., Oct. 7 /PRNewswire/ -- L...pansive campaign to bring a comprehensive diet and... Early Head Start,classrooms in an effort to have ...d diabetes in minority children. Lifelink also wil...
(Date:10/7/2008)...w! Everything a Man Wanted to Know But Was Afraid ...e are 4.3 million babies born,in the U.S. each yea...ntil,now. BEING DAD is a revealing, entertaining a... and experiences for dads-to-be from fathers who,h...ry process. It includes,a wealth of advice from se...
(Date:10/7/2008)...aged individuals show signs of awareness, unlike v...lthDay News) -- Severely brain-damaged patients i...n and require painkilling treatment, according to ...state (MCS) is different than a persistent vegetat...t awareness of self or surroundings. MCS patients ...
(Date:10/7/2008)... Oct. 7 /PRNewswire-USNewswire/ -- The Catholic He...conjunction with Catholic,Health Initiatives (CHI)...and Trinity Health, Novi, MI -- is launching a min...climate change., Through receipt of a $20,000 gra... Environment (NRPE) and the Catholic Coalition on,...
Breaking Medicine News(10 mins):Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3Health News:BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guy's Point of View 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2
...r, from the tender age of 4, known widely for his ...ck to his health. No, this was not an accidental f... On Thursday, Mr Diomande collapsed soon after a ...is due to inhalation of anthrax spores. This might...
...mportant position on the National Health Service’s...t month. The obvious reason, clinics in Britain ar...ransmitted diseases. // During a recent survey co... of facilities available, almost one in three doc...
...able-pants' heart failure therapy lack of conclusi...hat too little evidence exists to support a device...eart failure. // The technique in question is cal...a noninvasive therapy to improve blood flow to the...
...Government to distribute subsidized life-saving he... hepatitis C infected patients in Australia. // A...0) currently receive treatment for their condition...earliest, Australia might soon witness a rapid ris...
Other Medicine News:Health News:'Inflatable-pants' heart failure therapy suffers due to lack of evidence. 2
(Date:10/7/2008)...UVER, Oct. 7 / Burcon Nutra...at its Puratein(R) and,Supertein(TM) canola protei... for their intended use in a variety of food and b...affirmed GRAS through an,independent evaluation by...d safety, toxicology, nutritional sciences, food a...
(Date:10/7/2008)...- Data Presented Today at ACG Annual Scientific Me...all/ -- Ironwood,Pharmaceuticals, Inc. (formerly M...: FRX ) today announced the presentation of resul...afety and efficacy in 420 patients with,irritable ... of the data,indicates that once- daily oral dosin...
(Date:10/7/2008)...IEGO, Oct. 7 /- Ardea Biosc... a poster entitled "RDEA119, a Potent,and Highly S... Sulfate,Sodium (DSS) -- induced Chronic Colitis i...Gastroenterology (ACG) 2008 Annual Meeting in Orla... a preclinical study of,RDEA119, the Company,s lea...
(Date:10/6/2008)...ETON, N.J., Oct. 6 /- Pharm...d E.T. Smith, Ph.D., is joining the,Company as Vic...mmunications. Dr. Smith will be responsible for al...ectly to Chief Financial Officer Kurt,Leutzinger.,...d Senior Biotechnology,Analyst at JPMorgan Securit...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 1Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 2The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 1The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 2The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 3The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 4Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 3848 1Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 3848 2Los Angeles Finest Restaurants Wineries and Chefs Gather in Support of Sexual Health and Rights 13987 1Los Angeles Finest Restaurants Wineries and Chefs Gather in Support of Sexual Health and Rights 13987 2
...pr 26, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:...l 18, 2007 issue of the Journal of Neuroscience a ... and National Jewish,Medical and Research Center d...able catalytic antioxidant, AEOL 11207, demonstrat...,s disease ("PD").,The study also showed that the ...
...ess of Hypertension,Treatment Valsartan in Prevent...KYO, April 26, 2007 /Xinhua-PRNewswire/ -- The cli...-scale clinical trial,headed by the Jikei Universi...internationally renowned medical journal The,Lance...is one of,the largest cardiovascular intervention ...
Other Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 2First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 3First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 4
Conventional Digitally-Controlled Water Baths
...the Flavavirus group pf viruses. This virus is fou...ngue fever are the sudden onset of fever, headache...ulopapular rash and retrobulbar pain.,This test is...agnosis of anti-Dengue IgM antibodies. The Bio-Qua...
...the Flavavirus group pf viruses. This virus is fou...ngue fever are the sudden onset of fever, headache...ulopapular rash and retrobulbar pain.,This test is...agnosis of anti-Dengue IgG antibodies. The Bio-Qua...
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance.
Medicine Products: